Biocartis: Jumps on strong Q1 growth in commercial cartridges

Biocartis NV

22/04/2021 09:13

** Shares of Biocartis  BCART.BR  jump more than 7% after
molecular diagnostics co posted a strong Q1 commercial cartridge
volume performance 
    ** Commercial cartridge, used for specific diagnostics, grew
70% year-on-year in volume 
    ** Biocartis notes a strong performance in Europe, both in
oncology and in infectious diseases, and in the U.S., driven by
continued demand for the Idylla SARS-CoV-2 test  urn:newsml:reuters.com:*:nFWN2ME1C6
    ** "Biocartis' bet to turn the COVID-19 pandemic into an
opportunity has proven true, as it has jumped into the gap for
testing needs", KBC Securities says 
    ** Co, therefore, already takes head start on the road to
its 2021 guidance, brokerage adds
    ** Stock is heading for its best day since November 

 ((kate.entringer@thomsonreuters.com))